HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus

G. D. Sebastiani, M. Galeazzi, A. Tincani, R. Scorza, A. Mathieu, G. Passiu, G. Morozzi, J. C. Piette, R. Cervera, F. Houssiau, J. Smolen, A. Fernandez Nebro, E. De Ramon, A. Jedryka Goral, C. Papasteriades, G. B. Ferrara, C. Carcassi, F. Bellisai, R. Marcolongo

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Our objective was to determine the HLA-DPB1 allele associations of anticardiolipin (aCL) and anti-beta2GPI (aβ2GPI) antibodies, and of clinical manifestations of the antiphospholipid syndrome (APS), in systemic lupus erythematosus (SLE). We studied 577 European patients with SLE. aCL and aβ2GPI antibodies were measured by ELISA. Molecular typing of HLA-DPB1 locus was performed by polymerase chain reaction-sequence specific oligonucleotide probe (PCR-SSOP) method. aCL showed positive association with -DPB1*1501 (P = 0.005, OR = 7.4), and -DPB1*2301 (P = 0.009, OR = 3.3). aβ2GPI showed positive association with -DPB1*0301 (P = 0.01, OR = 1.9), and -DPB1*1901 (P = 0.004, OR = 8.1). In addition, livedo reticularis was associated with -DPB1*1401, and Raynaud's phenomenon with -DPB1*2001. In conclusion, HLA-DPB1 locus may contribute to the genetic predisposition to develop antiphospholipid antibodies and clinical manifestations of the APS in patients with SLE.

Original languageEnglish
Pages (from-to)560-563
Number of pages4
JournalLupus
Volume12
Issue number7
DOIs
Publication statusPublished - 2003

Fingerprint

Systemic Lupus Erythematosus
Anti-Idiotypic Antibodies
Antiphospholipid Syndrome
Alleles
Livedo Reticularis
Molecular Typing
Raynaud Disease
Antiphospholipid Antibodies
Oligonucleotide Probes
Genetic Predisposition to Disease
Enzyme-Linked Immunosorbent Assay
Polymerase Chain Reaction
HLA-DPB1 antigen

Keywords

  • Anti-βGPI antibodies
  • Anticardiolipin antibodies
  • Antiphospholipid syndrome
  • HLA
  • HLA-DPB1 locus
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Sebastiani, G. D., Galeazzi, M., Tincani, A., Scorza, R., Mathieu, A., Passiu, G., ... Marcolongo, R. (2003). HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus, 12(7), 560-563. https://doi.org/10.1191/0961203303lu402oa

HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. / Sebastiani, G. D.; Galeazzi, M.; Tincani, A.; Scorza, R.; Mathieu, A.; Passiu, G.; Morozzi, G.; Piette, J. C.; Cervera, R.; Houssiau, F.; Smolen, J.; Fernandez Nebro, A.; De Ramon, E.; Jedryka Goral, A.; Papasteriades, C.; Ferrara, G. B.; Carcassi, C.; Bellisai, F.; Marcolongo, R.

In: Lupus, Vol. 12, No. 7, 2003, p. 560-563.

Research output: Contribution to journalArticle

Sebastiani, GD, Galeazzi, M, Tincani, A, Scorza, R, Mathieu, A, Passiu, G, Morozzi, G, Piette, JC, Cervera, R, Houssiau, F, Smolen, J, Fernandez Nebro, A, De Ramon, E, Jedryka Goral, A, Papasteriades, C, Ferrara, GB, Carcassi, C, Bellisai, F & Marcolongo, R 2003, 'HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus', Lupus, vol. 12, no. 7, pp. 560-563. https://doi.org/10.1191/0961203303lu402oa
Sebastiani, G. D. ; Galeazzi, M. ; Tincani, A. ; Scorza, R. ; Mathieu, A. ; Passiu, G. ; Morozzi, G. ; Piette, J. C. ; Cervera, R. ; Houssiau, F. ; Smolen, J. ; Fernandez Nebro, A. ; De Ramon, E. ; Jedryka Goral, A. ; Papasteriades, C. ; Ferrara, G. B. ; Carcassi, C. ; Bellisai, F. ; Marcolongo, R. / HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. In: Lupus. 2003 ; Vol. 12, No. 7. pp. 560-563.
@article{15dac8b22fe24c59881803daa4b592ea,
title = "HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus",
abstract = "Our objective was to determine the HLA-DPB1 allele associations of anticardiolipin (aCL) and anti-beta2GPI (aβ2GPI) antibodies, and of clinical manifestations of the antiphospholipid syndrome (APS), in systemic lupus erythematosus (SLE). We studied 577 European patients with SLE. aCL and aβ2GPI antibodies were measured by ELISA. Molecular typing of HLA-DPB1 locus was performed by polymerase chain reaction-sequence specific oligonucleotide probe (PCR-SSOP) method. aCL showed positive association with -DPB1*1501 (P = 0.005, OR = 7.4), and -DPB1*2301 (P = 0.009, OR = 3.3). aβ2GPI showed positive association with -DPB1*0301 (P = 0.01, OR = 1.9), and -DPB1*1901 (P = 0.004, OR = 8.1). In addition, livedo reticularis was associated with -DPB1*1401, and Raynaud's phenomenon with -DPB1*2001. In conclusion, HLA-DPB1 locus may contribute to the genetic predisposition to develop antiphospholipid antibodies and clinical manifestations of the APS in patients with SLE.",
keywords = "Anti-βGPI antibodies, Anticardiolipin antibodies, Antiphospholipid syndrome, HLA, HLA-DPB1 locus, Systemic lupus erythematosus",
author = "Sebastiani, {G. D.} and M. Galeazzi and A. Tincani and R. Scorza and A. Mathieu and G. Passiu and G. Morozzi and Piette, {J. C.} and R. Cervera and F. Houssiau and J. Smolen and {Fernandez Nebro}, A. and {De Ramon}, E. and {Jedryka Goral}, A. and C. Papasteriades and Ferrara, {G. B.} and C. Carcassi and F. Bellisai and R. Marcolongo",
year = "2003",
doi = "10.1191/0961203303lu402oa",
language = "English",
volume = "12",
pages = "560--563",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "7",

}

TY - JOUR

T1 - HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus

AU - Sebastiani, G. D.

AU - Galeazzi, M.

AU - Tincani, A.

AU - Scorza, R.

AU - Mathieu, A.

AU - Passiu, G.

AU - Morozzi, G.

AU - Piette, J. C.

AU - Cervera, R.

AU - Houssiau, F.

AU - Smolen, J.

AU - Fernandez Nebro, A.

AU - De Ramon, E.

AU - Jedryka Goral, A.

AU - Papasteriades, C.

AU - Ferrara, G. B.

AU - Carcassi, C.

AU - Bellisai, F.

AU - Marcolongo, R.

PY - 2003

Y1 - 2003

N2 - Our objective was to determine the HLA-DPB1 allele associations of anticardiolipin (aCL) and anti-beta2GPI (aβ2GPI) antibodies, and of clinical manifestations of the antiphospholipid syndrome (APS), in systemic lupus erythematosus (SLE). We studied 577 European patients with SLE. aCL and aβ2GPI antibodies were measured by ELISA. Molecular typing of HLA-DPB1 locus was performed by polymerase chain reaction-sequence specific oligonucleotide probe (PCR-SSOP) method. aCL showed positive association with -DPB1*1501 (P = 0.005, OR = 7.4), and -DPB1*2301 (P = 0.009, OR = 3.3). aβ2GPI showed positive association with -DPB1*0301 (P = 0.01, OR = 1.9), and -DPB1*1901 (P = 0.004, OR = 8.1). In addition, livedo reticularis was associated with -DPB1*1401, and Raynaud's phenomenon with -DPB1*2001. In conclusion, HLA-DPB1 locus may contribute to the genetic predisposition to develop antiphospholipid antibodies and clinical manifestations of the APS in patients with SLE.

AB - Our objective was to determine the HLA-DPB1 allele associations of anticardiolipin (aCL) and anti-beta2GPI (aβ2GPI) antibodies, and of clinical manifestations of the antiphospholipid syndrome (APS), in systemic lupus erythematosus (SLE). We studied 577 European patients with SLE. aCL and aβ2GPI antibodies were measured by ELISA. Molecular typing of HLA-DPB1 locus was performed by polymerase chain reaction-sequence specific oligonucleotide probe (PCR-SSOP) method. aCL showed positive association with -DPB1*1501 (P = 0.005, OR = 7.4), and -DPB1*2301 (P = 0.009, OR = 3.3). aβ2GPI showed positive association with -DPB1*0301 (P = 0.01, OR = 1.9), and -DPB1*1901 (P = 0.004, OR = 8.1). In addition, livedo reticularis was associated with -DPB1*1401, and Raynaud's phenomenon with -DPB1*2001. In conclusion, HLA-DPB1 locus may contribute to the genetic predisposition to develop antiphospholipid antibodies and clinical manifestations of the APS in patients with SLE.

KW - Anti-βGPI antibodies

KW - Anticardiolipin antibodies

KW - Antiphospholipid syndrome

KW - HLA

KW - HLA-DPB1 locus

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=0038038335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038038335&partnerID=8YFLogxK

U2 - 10.1191/0961203303lu402oa

DO - 10.1191/0961203303lu402oa

M3 - Article

VL - 12

SP - 560

EP - 563

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 7

ER -